18 April 2025 (Friday) - ASH Update

The nice people at the American Society of Hematology sent an update about various clinical trials today. Perhaps a tad over my head, but all useful stuff…

Clinical Trials Corner
 
 
 
Can Abelacimab Attenuate the Risk of Bleeding in Patients With Atrial Fibrillation? 
 
Michael Scott, MD, MHPE
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202537
 
 
Committee Corner
 
 
 
Committee Corner The ASH Foundation Is a Reflection of the Society 
 
James Labelle, MD, PhD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.2025310
 
 
Diffusion
 
 
 
Better Together? Combining Teclistamab and Talquetamab in RedirecTT-1 
 
Darren Pan, MD ; Anupama D. Kumar, MDJodi J. Lipof, MDAlfred Chung, MDAjai Chari, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.2025311
 
 
Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 
 
Scott Furlan, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.2025312
 
 
Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia 
 
Tycel Phillips, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.2025313
 
 
Debunking the Myth: Sickle Cell Trait and Exertion-Related Deaths — A Review of the Evidence 
 
Chinonso Onuoha, MD ; Samuel R. Wilson, MD, MSCRPatrick Ellsworth, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202536
 
 
Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia 
 
Emily Wolf, MDEwa Wysokinska, MDSurbhi Shah, MBBS, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202535
 
 
Will CAR T Cells Ever Work in Acute Myeloid Leukemia? Perhaps, If We Follow the Cytokines 
 
Lori Muffly, MD, MS
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202533
 
 
CRISPR-Based Diagnostic Assay for Acute Promyelocytic Leukemia 
 
Elizabeth L. Courville, MD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202531
 
 
DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma 
 
Zachary Graff, MDLauren Pommert, MD, MS
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202534
 
 
Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments 
 
Brian T. Hill, MD, PhD
 
April 2025, Vol.22, . doi: 10.1182/hem.V22.3.202532

No comments:

Post a Comment